Naproxen compared to placebo for cellulitis treatment
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests whether adding the anti-inflammatory medicine naproxen to your usual antibiotic treatment helps you recover faster from cellulitis (a painful skin infection). If you are being treated at home with oral antibiotics, this study may help reduce swelling and pain while your infection clears.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a doctor-diagnosed skin infection called cellulitis.
- Your doctor must plan to treat you with oral antibiotics at home (not in the hospital).
- You cannot have a skin abscess (a pus-filled bump that needs to be drained).
- You cannot be taking certain blood thinners or have certain medical conditions like severe heart failure, kidney problems, or a history of stomach ulcers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two antibiotics, moxifloxacin and clindamycin, to see which works better for treating dental infections that can be managed in a clinic. If you have a dental infection that needs a minor procedure and antibiotics, this trial could help find the best treatment.
This trial tests whether a short course of amoxicillin (an antibiotic) is as effective as the standard, longer course for treating erysipelas, a bacterial skin infection that causes redness, swelling, and pain in the lower legs. If you qualify, you would take the antibiotic for either 6 or 12 days, which may mean fewer side effects and a quicker return to your normal routine.
This Phase 3 study compares 5 days versus 7 days of antibiotic treatment for new leg cellulitis (skin infection). It may help you get the right treatment duration while keeping side effects and recovery in mind.
This trial looks at whether a simpler antibiotic plan can work for children with uncomplicated bone or joint infections that start in the community. It may help reduce the need for complicated treatment while still keeping the infection under control.
This trial tests whether the antibiotic cefotetan works as well as current standard treatments for E. coli bloodstream infections that start in the urinary tract. If you qualify, you may receive either cefotetan or the usual antibiotic therapy.
This trial compares two antibiotics, cloxacillin and benzylpenicillin, to see which works better for patients with a bloodstream infection caused by a specific type of staph bacteria that responds well to penicillin. It may help guide more effective treatment.
Hear when a new Cellulitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.